Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

Fig. 2

Exo MSC-NTF increase O2 saturation in an LPS lung injury mouse model. a Experimental setup. Mice received intratracheal (IT) treatment of 800 μg LPS followed by three treatments with Exo MSC, Exo MSC-NTF, or vehicle (PlasmaLyte), 3 h, 24 h, and 48 h after LPS exposure. b O2 saturation 24 h, 48 h, and 72 h following LPS/vehicle injection. Mean ± SEM, n = 9–13. *p < 0.05, **p < 0.01, ***p < 0.001 vs. LPS + PlasmaLyte group. Repeated measurements two-way ANOVA followed by Tukey’s post hoc

Back to article page
\